Aerie Pharmaceuticals
Innovative ophthalmic therapies for glaucoma, dry eye, and retinal diseases. Learn more
Launch date
Employees
Market cap
AUD1.2b
Enterprise valuation
AUD1.4b (Public information from Nov 2022)
Share price
$15.25 AERI
Durham North Carolina (HQ)
Authorizing premium user...